Cost-effectiveness of extracorporeal membrane oxygenation in patients with acute respiratory distress syndrome in Colombia

Alex García, Nelson Darío Giraldo , .

Keywords: Extracorporeal membrane oxygenation, respiratory distress syndrome, respiration, artificial, cost-benefit analysis, mechanical ventilation, Colombia

Abstract

Introduction: Extracorporeal membrane oxygenation therapy is expensive. There is evidence in the literature that it can be a cost-effective intervention in developed countries; however, in countries with low gross domestic product per capita, such as Colombia, there are still some doubts.
Objective: To determine the incremental cost-effectiveness ratio of extracorporeal membrane oxygenation in patients with acute respiratory distress syndrome in Colombia.
Materials and methods: Cost-effectiveness analysis in healthcare in relation to adult patients diagnosed with acute respiratory distress syndrome with mechanical ventilation with low volumes compared to extracorporeal membrane oxygenation. The direct medical costs and the incremental cost-effectiveness ratio were determined at 6 months.
Results: The expected cost per patient on protective mechanical ventilation was COP$17,609,909. The cost of extracorporeal membrane oxygenation therapy support in surviving patients was COP$ 98,784,116. The average cost-effectiveness ratio of extracorporeal membrane oxygenation was COP$ 141,662,435 for each life saved (USD$ 41,276).
Conclusions: Support with extracorporeal membrane oxygenation therapy had an average cost of COP$ 141,662,435 for each life saved equivalent to USD$ 41,276. The incremental cost-effectiveness ratio COP$ was 608,783,750 (USD$ 177,384); almost ten times higher than the decision rule of three gross domestic product per capita (COP$ 59,710,479).

Downloads

Download data is not yet available.
  • Alex García Departamento de Anestesiología y Reanimación, Universidad de Antioquia, Medellín, Colombia; Departamento de Medicina Crítica y Cuidados Intensivos, Hospital Pablo Tobón Uribe, Medellín, Colombia https://orcid.org/0000-0003-1803-878X
  • Nelson Darío Giraldo Departamento de Medicina Crítica y Cuidados Intensivos, Hospital Pablo Tobón Uribe, Medellín, Colombia; Unidad de Cuidados Intensivos Cardiovascular, Clínica CardioVid, Medellín, Colombia https://orcid.org/0000-0002-4068-6209

References

Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685-93. https://doi.org/10.1056/NEJMoa050333

Asbaugh D, Bigelow B, Petty T, Levine B. Acute respiratory distress in adults. Lancet. 1967;290:319-23. https://doi.org/10.1016/s0140-6736(67)90168-7

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788-800. https://doi.org/10.1001/jama.2016.0291

Varón-Vega FA, Uribe Hernández AM, Palacios Rojas JO. Epidemiología, diferencias clínicas y desenlaces de pacientes con SDRA en unidades de cuidado intensivo de Colombia. Acta Colombiana de Cuidado Intensivo. 2019;19:74-80. https://doi.org/10.1016/j.acci.2019.01.005

Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019;380:1997-2008. https://doi.org/10.1056/NEJMoa1901686

Lee JM, Bae W, Lee YJ, Cho YJ. The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: Updated study-level meta-analysis of 11 randomized controlled trials. Crit Care Med. 2014;42:1252-62. https://doi.org/10.1097/CCM.0000000000000122

Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965-75. https://doi.org/10.1177/1054773816677808

Barrett KA, Hawkins N, Fan E. Economic evaluation of venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Crit Care Med. 2019;47:186-93. https://doi.org/10.1097/CCM.0000000000003465

Combes A, Peek GJ, Hajage D, Hardy P, Abrams D, Schmidt M, et al. ECMO for severe ARDS: Systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46:2048-57. https://doi.org/10.1007/s00134-020-06248-3

Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome advances in diagnosis and treatment. JAMA. 2018;319:698-710. https://doi.org/10.1001/jama.2017.21907

Salazar LA, Uribe JD, Poveda Henao CM, Santacruz CM, Giraldo Bejarano E, Bautista DF, et al. Consenso ECMO colombiano para paciente con falla respiratoria grave asociada a COVID-19. Acta Colombiana de Cuidado Intensivo. 2021;21:272-82. https://doi.org/10.1016/j.acci.2020.09.001

Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet. 2009;374:1351-63. https://doi.org/10.1016/S0140-6736(09)61069-2

Hamel MB, Phillips RS, Davis RB, Teno J, Connors AF, Desbiens N, et al. Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med. 2000;109:614-20. https://doi.org/10.1016/s0002-9343(00)00591-x

Bice T, Carson SS. Acute respiratory distress syndrome: Cost (early and long-term). Semin Respir Crit Care Med. 2019;40:137-44. https://doi.org/10.1055/s-0039-1685463

Moreno M, Mejía A, Castro H. Manual para la elaboración de evaluaciones económicas en salud. Bogotá, D.C.: Instituto de Evaluación Tecnológica en Salud; 2014. p. 10-32.

Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. O’Brien BJ. Methods for the economic evaluation of health care programmes. Fourth edition. Oxford: Oxford University Press; 2015. p. 1-445.

Zampieri FG, Mendes PV, Ranzani OT, Taniguchi LU, Pontes Azevedo LC, Vieira Costa EL, et al. Extracorporeal membrane oxygenation for severe respiratory failure in adult patients: A systematic review and meta-analysis of current evidence. J Crit Care. 2013;28:998-1005. https://doi.org/10.1016/j.jcrc.2013.07.04

Herridge M, Tansay C, Matté A, Tomlinson G, Díaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293-304. https://doi.org/10.1056/NEJMoa1011802

Skinner EH, Denehy L, Warrillow S, Hawthorne G. Comparison of the measurement properties of the AQoL and SF-6D in critical illness. Crit care Resusc. 2013;15:205-12.

Ramanathan K, Shekar K, Ling RR, Barbaro RP, Wong SN, Tan CS, et al. Extracorporeal membrane oxygenation for COVID-19: A systematic review and meta-analysis. Crit Care. 2021;25:1-11. https://doi.org/10.1186/s13054-021-03634-1

How to Cite
1.
García A, Giraldo ND. Cost-effectiveness of extracorporeal membrane oxygenation in patients with acute respiratory distress syndrome in Colombia. biomedica [Internet]. 2022 Dec. 1 [cited 2024 May 19];42(4):707-16. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/6386

Some similar items:

Published
2022-12-01
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code